Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06496555

Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study

The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO) criteria. We designed five aspects including the overall fitting effecience evaluation, calibration curve, quantifying calibration performance, quantifying discrimination performance, quantifying clinical utility to evaluate the external validation model.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

Location status: Recruiting

Location contact

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • critically ill patients who stayed in ICU for over 24 h;
  • patients older than 18 years of age.

Exclusion criteria

  • patients who admitted in ICU had been diagnosed acute kidney injury;
  • patients who admitted in ICU had been diagnosed acute kidney disease;
  • patients who admitted in ICU had been diagnosed chronic kidney disease;
  • patients who admitted in ICU had performed kidney dialysis;
  • patients who admitted in ICU had performed kidney transplantation;
  • Pregnant women.

Treatment and study plan

Primary outcomes

  1. AKI occurrence

    Time frame: 12 hours

Study contacts

Contact information is provided by the study sponsor or research team.

Tao Sun, Doctor

CONTACT

[email protected]

0571-87783752

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 11, 2024
Registry last updated
Jul 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.